Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chan He

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Frontiers in Oncology|November 12, 2020
A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal CancersXuan Su, Hui-Chan He, Zu-Lu Ye, et al.
Oncology Research and Treatment|January 25, 2017
Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile CancerYue-Ping Wan, Ming Xi, Hui-Chan He, et al.
BMC Genomics|November 7, 2013
Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patientsHui-chan He, Zhao-dong Han, Qi-shan Dai, et al.
Molecular and Cellular Biochemistry|May 14, 2013
Expression of SOCSs in human prostate cancer and their association in prognosisJian-guo Zhu, Qi-shan Dai, Zhao-dong Han, et al.
Pathology Oncology Research : POR|August 24, 2011
Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcomeHui-Chan He, Jia-Hong Chen, Xi-Bin Chen, et al.
Medical Oncology (Northwood, London, England)|November 1, 2011
Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese populationJia-hong Chen, Hui-chan He, Fu-neng Jiang, et al.
Pathology Oncology Research : POR|April 19, 2011
Classical and alternative nuclear factor-κB pathways: a comparison among normal prostate, benign prostate hyperplasia and prostate cancerChao Cai, Fu-neng Jiang, Yu-xiang Liang, et al.
Biomed Research International|September 9, 2014
CC chemokine ligand 18 correlates with malignant progression of prostate cancerGuo Chen, Yu-xiang Liang, Jian-guo Zhu, et al.
Molecular Biology Reports|January 24, 2014
MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancerXiao-hui Ling, Zhao-dong Han, Dan Xia, et al.
FEBS Letters|June 20, 2012
MicroRNA-23b downregulates peroxiredoxin III in human prostate cancerHui-chan He, Jian-guo Zhu, Xi-bin Chen, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Frontiers in Oncology|November 12, 2020
A 10-Year Study on Larynx Preservation Compared With Surgical Resection in Patients With Locally Advanced Laryngeal and Hypopharyngeal CancersXuan Su, Hui-Chan He, Zu-Lu Ye, et al.
Oncology Research and Treatment|January 25, 2017
Expression and Clinical Significance of SOX9 in Renal Cell Carcinoma, Bladder Cancer and Penile CancerYue-Ping Wan, Ming Xi, Hui-Chan He, et al.
BMC Genomics|November 7, 2013
Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patientsHui-chan He, Zhao-dong Han, Qi-shan Dai, et al.
Molecular and Cellular Biochemistry|May 14, 2013
Expression of SOCSs in human prostate cancer and their association in prognosisJian-guo Zhu, Qi-shan Dai, Zhao-dong Han, et al.
Pathology Oncology Research : POR|August 24, 2011
Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcomeHui-Chan He, Jia-Hong Chen, Xi-Bin Chen, et al.
Medical Oncology (Northwood, London, England)|November 1, 2011
Analysis of the specific pathways and networks of prostate cancer for gene expression profiles in the Chinese populationJia-hong Chen, Hui-chan He, Fu-neng Jiang, et al.
Pathology Oncology Research : POR|April 19, 2011
Classical and alternative nuclear factor-κB pathways: a comparison among normal prostate, benign prostate hyperplasia and prostate cancerChao Cai, Fu-neng Jiang, Yu-xiang Liang, et al.
Biomed Research International|September 9, 2014
CC chemokine ligand 18 correlates with malignant progression of prostate cancerGuo Chen, Yu-xiang Liang, Jian-guo Zhu, et al.
Molecular Biology Reports|January 24, 2014
MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancerXiao-hui Ling, Zhao-dong Han, Dan Xia, et al.
FEBS Letters|June 20, 2012
MicroRNA-23b downregulates peroxiredoxin III in human prostate cancerHui-chan He, Jian-guo Zhu, Xi-bin Chen, et al.
Pageof 10